Efficacy and Safety of Long-Term Tildrakizumab for Plaque Psoriasis: 4-Year Results from Resurface 1 and Resurface 2. J of Skin [Internet]. 2020 Sep. 2 [cited 2026 Apr. 19];4(5):s39. Available from: https://skin.dermsquared.com/skin/article/view/988